This Article
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
CMAJ • October 30, 2001; 165 (9)
© 2001 Canadian Medical Association or its licensors

Corrections

In a recent letter to the editor by Kevin Kain,1 the first sentence of the second paragraph should read as follows: "Unfortunately, artemisinin-based drugs have not been shown to be better than parenteral quinine (the current drug of choice in Canada) in decreasing the mortality associated with severe malaria.2,3"

References

  1. Kain C. Ammunition against malaria [letter]. CMAJ 2001;165(5):529.[Free Full Text]
  2. Tran TH, Day NP, Nguyen HP, Nguyen TH, Tran TH, Pham PL, et al. A controlled trial of artemether or quinine in Vietnamese adults with severe falciparum malaria. N Engl J Med 1996;335(2):76-83.[Abstract/Free Full Text]
  3. Van Hensbroek MB, Onyiorah E, Jaffar S, Schneider G, Palmer A, Frenkel J, et al. A trial of artemether or quinine in children with cerebral malaria. N Engl J Med 1996;335(2):69-75. [Abstract/Free Full Text]




This Article
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content